Pramipexole versus dual release levodopa in restless legs syndrome: a double blind, randomised, cross-over trial
QUESTIONS UNDER STUDY: To compare efficacy and safety of the dopamine agonist pramipexole (PPX) versus reference treatment with dual release levodopa/benserazide (L/B) in de novo patients with restless legs syndrome (RLS). METHODS: A total of 39 men and women between 25 and 85 years o...
Main Authors: | F Bornatico, J Schwander |
---|---|
Format: | Article |
Language: | English |
Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2011-11-01
|
Series: | Swiss Medical Weekly |
Subjects: | |
Online Access: | https://www.smw.ch/index.php/smw/article/view/1388 |
Similar Items
-
Factors Affecting the Efficacy of Pramipexole in Patients with Restless Legs Syndrome
by: Mohammad Rezvani, et al.
Published: (2013-06-01) -
Factors Affecting the Efficacy of Pramipexole in Patients with Restless Legs Syndrome
by: Mohammad Rezvani, et al.
Published: (2013-06-01) -
Chronic back pain cured by low-dose levodopa: is it a variant of restless legs syndrome?
by: Zeng Z, et al.
Published: (2018-02-01) -
Comparison of the effects of pramipexole and gabapentin on the treatment of restless leg syndrome in end-stage chronic renal failure patients undergoing hemodialysis
by: Sepideh Hajian, et al.
Published: (2020-07-01) -
Restless leg syndrome, periodic limb movements, febrile seizures and Attention deficit hyperactivity disorder in an Indian family
by: Meena Gupta, et al.
Published: (2012-01-01)